Organization
The Medicines Co.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
The Medicines Co.
... a dozen biopharmaceutical companies. The hope: development of a new class of medicines that can mimic Pete's genes, to treat families like Millius', and the ...
... The Medicines Company (NASDAQ:MDCO) today announced that its Board of Directors has appointed Fredric ...
... The Medicines Company has tweaked its board, bringing former Pfizer executive Geno Germano in ...
... Geneva - The Medicines Patent Pool and the United States Agency for International Development (USAID) ...
... If you want a Stock Review on MDCO, MNTA, DPLO, or ZTS then come over tohttp://dailystocktracker.com/register/and sign up for your ...
... The Medicines Company (NASDAQ: MDCO) and Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) today announced the initiation ...
... unrivalled knowledge of the pharmaceutical sector and proven success in bringing new medicines successfully to clinic. Professor Colin Riordan, Vice-Chancellor of Cardiff University, said: 'With ...
... Review Committee to evaluate product developers' study protocols and development plans. About the Medicines Patent Pool The Medicines Patent Pool is a United Nations-backed public ...
... PARSIPPANY, N.J. - The Medicines Company (NASDAQ: MDCO) today reported its financial results for the third quarter ended ...
... The Medicines Company (NASDAQ: MDCO) today reported its financial results for the third quarter ended ...
... PARSIPPANY, N.J. - The Medicines Company (NASDAQ:MDCO) will host a conference call on Wednesday, October 25, 2017, ...
... TheMedicines Company (NASDAQ:MDCO) will host a conference call on Wednesday, October 25, 2017, at ...
... Geneva - The Medicines Patent Pool (MPP) announced that it has signed a Memorandum of ...
... PARSIPPANY, N.J - The Medicines Company (NASDAQ:MDCO) today announced that new data from its TANGO II study ...
... The Medicines Company (NASDAQ:MDCO) today announced that new data from its TANGO II study ...
... If you want a Stock Review on MNTA, MDCO, DPLO, or ZTS then come over tohttp://dailystocktracker.com/register/and sign up for your free ...
... The Medicines Patent Pool (MPP) today announced a licence with Gilead Sciences for ...
... Gilead Sciences, Inc. (NASDAQ:GILD) announced today a new licensing agreement with the Medicines Patent Pool (MPP), a United Nations-backed public health organization, to expand ...
... PARSIPPANY, N.J. - The Medicines Company (NASDAQ:MDCO) today announced that data from its portfolio of antimicrobial products ...
... at IDWeek 2017 to be heldOctober 4-8, 2017 in San Diego. The Medicines Company's infectious disease research and product development is focused on the most ...
... new results from a number of studies across 18 approved and investigational medicines will be presented during the European Society for Medical Oncology (ESMO) Congress ...
... PARSIPPANY, N.J. - The Medicines Company (NASDAQ:MDCO) today announced that the U.S. Food and Drug Administration (FDA) ...
... the antibacterial meropenem and vaborbactam, a component to combat bacterial resistance. The Medicines Company won approval for the new antibacterial, which is set for launch ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤